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With the medicine enterprises to speed up the process of their globalization, increase 
in their market concentration and compete increasingly in pharmaceutical industry, the 
market competitiveness of enterprises is more focused on optimizing internal 
management and speeding response to market demand. An increasing number of 
enterprises in their internal management will penetrate the financial management 
concept in various fields and sections, with a view to enhance the management level of 
enterprises and their competitiveness. 
The management of procurement, which is the source of the cost and quality in 
medicine enterprises, plays a prominent position in business operations management. 
As a developing enterprise in domestic market, Company C is in a rapid runway repair 
of its scale expansion. Purchase costs, as the principal and core of company’s cost 
control, becomes bottlenecks for the enterprise development. With the age of a high 
homogenization in the medical products and the low-profit in the entire medicine 
industry coming, Company C is facing many problems, e.g. the total cost always staying 
at the top, high turnover inefficiency and enterprise profits stop waiting, etc. Therefore, 
establishing a financial concept in the procurement management, using financial ideas 
to improve medicine procurement management, lowering overall procurement cost, 
improving the efficiency of procurement management and promoting the overall 
efficiency, are very important for the company’ future survival and development. 
  Taking the above as a starting point, using the related theories of corporate financial 
management and procurement management, combining with the characteristic of 
medicine procurement management, the paper analyzes the current situation and 
existing problems of Company C’s medicine procurement management. It puts forward 
that in the basis of company finance concept which guiding for the capital management, 
implementing rational procurement strategies, raising the efficiency of capital turnover, 
achieving the intensive total procurement cost and the maximizing efficiency, and 















Using the company's core theory ─ the capital stock management, the incremental 
management, the configuration management and the revenue management, this paper 
attempts to analysis the key sections and constraints in Company C’s medicine 
procurement and puts forward reasonable suggestions. 
In the aspect of capital gains management in medicine procurement, this paper takes 
the management of medicine procurement cost, human resources and performance as 
main study fields. It takes the medicine inventory cycle management and quality 
management as major research directions in the capital stock management of medicine 
procurement. In the matter of capital increment management in medicine procurement, 
it mainly studies the procurement scale management, procurement capital management 
and procurement technical management. In terms of configuration management in 
medicine procurement, it concerns the optimizing structure in medicine, the capital 
allocation and payments configuration management.  
Using the guidance of capital management for corporate finance concept in the whole 
process of medicine procurement management, the company strives to improve the 
efficiency of capital turnover, reduce the overall cost of medicine procurement and 
improve the efficiency and level of the procurement management, so as to achieve the 
goal of maximizing corporate efficiency. 
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第 1 章  绪 论 
1.1  论文选题背景 











































1.2  论文的理论基础 
1.2.1  公司理财的相关理论 
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